Deliver Your News to the World

NOW FDA approved for clinical use Measuring the APC Resistance associated with Factor V-L, quantitatively Second generation screenig assay for APC-R.


NEW CONCEPT FOR FV-LEIDEN Second generation for screening for APC-R. Reducing cost up to 50%/test compared to the old way of screening for APC-R. This new method is only available through Hyphen BioMed/Aniara.

For more information please follow the link below:

HEMOCLOT Quanti. V-L (ACK065L)kit is a clotting method proposed for measuring Factor V-L (Factor V Leiden) concentration in citrated plasma, by its resistance to the action of Activated Protein C (APC). The assay is performed in the presence of Activated Protein C. In presence of APC and Protein S (in excess), the prolongation of clotting time is directly related to the concentration of Normal Factor V, and inversely related to the amount of Factor V-Leiden (mutation R506Q).

Assay characteristics

.Quantitative reagent for measuring Factor V-L.

.No interference of plasma factor deficiencies (Other than that of Factor V).

.Excellent discrimination between Heterozygous, Homozygous and Normalís.

.Single test method performed with only a Clotting Time (CT).

Literature Links:

ISTH Poster:

Product SKU and Pricing Information

HEMOCLOT Quanti V-L 510K/CE Cleared Clotting Set of 3x20 tests ACK065K $225

Factor V-L Calibrator 510K/CE Cleared Set of 3 (4x1 ml) ASC065K $125

V-L CAL (Undiluted) 510K/CE Cleared 2x3x0.5 ml A222401 $125

BIOPHEN Normal Control Plasma 510k/CE Cleared 12x1 ml A223201 $175

Act PC-r Control Plasma 510K/CE Cleared 12x0.5 ml A223405 $195

Jonas Kingo

Executive Vice President of Global Marketing and Sales


 APC Resistance
 Factor V Leiden
 APC-R screening assay
 test for apc r

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.